Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Buy
29,943
+232
+0.8% +$14.1K 0.01% 817
2026
Q1
$1.46M Buy
29,711
+3,061
+11% +$143K 0.01% 1082
2025
Q4
$959K Sell
26,650
-373
-1% -$15.1K 0.01% 1239
2025
Q3
$1.22M Buy
27,023
+78
+0.3% +$3.16K 0.01% 992
2025
Q2
$855K Buy
26,945
+7,682
+40% +$220K 0.01% 1062
2025
Q1
$585K Buy
19,263
+11,805
+158% +$416K 0.01% 1066
2024
Q4
$270K Buy
+7,458
New +$292K ﹤0.01% 1389

Other funds holding CGNX

&Partners's CGNX Position: Q2 2026 in Review

&Partners increased its Cognex (CGNX) stake by 0.78% in Q2 2026, buying an estimated $14.1K and bringing the position to 29,943 shares worth $2.91M. The position accounts for 0.01% of the portfolio, ranked #817.

&Partners first reported a position in CGNX in Q4 2024 and has held it in 7 quarters since. 651 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • &Partners held 29,943 shares of Cognex worth $2.91M as of Q2 2026.
  • &Partners bought 232 Cognex shares in Q2 2026, an estimated $14.1K.
  • Cognex made up 0.01% of &Partners's portfolio in Q2 2026, its #817 holding.
  • &Partners first reported a position in Cognex in Q4 2024 and has held it in 7 quarters since.
  • 651 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.